Jeffrey Jones to Prospective Studies
This is a "connection" page, showing publications Jeffrey Jones has written about Prospective Studies.
Connection Strength
0.012
-
Phase II study of flavopiridol in relapsed chronic lymphocytic leukemia demonstrating high response rates in genetically high-risk disease. J Clin Oncol. 2009 Dec 10; 27(35):6012-8.
Score: 0.012